Epigenetic changes in virus-associated neoplasms

Patho-Epigenetics of Disease

Volumn 9781461433453, Issue , 2012, Pages 179-225

  Niller, Hans Helmut ^a   Banati, Ferenc ^b   Ay, Eva ^b   Minarovits, Janos ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949179696     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3345-3_8     Document Type: Chapter

References (217)

1. Anastasiadou, E., Boccellato, F., Vincenti, S., Rosato, P., Bozzoni, I., Frati, L., Faggioni, A., Presutti, C. & Trivedi, P. (2010). Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene 29, 1316-1328.
2. Anderton, J. A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Christensen, J., Rowe, M., Murray, P. G. & Woodman, C. B. (2011). The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma. Oncogene 30, 2037-2043.
3. Araujo, I., Foss, H. D., Hummel, M., Anagnostopoulos, I., Barbosa, H. S., Bittencourt, A. & Stein, H. (1999). Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol 187, 326-330.
4. Arora, P., Kim, E. O., Jung, J. K. & Jang, K. L. (2008). Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 261, 244-252.
5. Balassiano, K., Lima, S., Jenab, M., Overvad, K., Tjonneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Canzian, F., Kaaks, R., Boeing, H., Meidtner, K., Trichopoulou, A., Laglou, P., Vineis, P., Panico, S., Palli, D., Grioni, S., Tumino, R., Lund, E., Bueno-de-Mesquita, H. B., Numans, M. E., Peeters, P. H., Ramon, Q. J., Sanchez, M. J., Navarro, C., Ardanaz, E., Dorronsoro, M., Hallmans, G., Stenling, R., Ehrnstrom, R., Regner, S., Allen, N. E., Travis, R. C., Khaw, K. T., Offerhaus, G. J., Sala, N., Riboli, E., Hainaut, P., Scoazec, J. Y., Sylla, B. S., Gonzalez, C. A. & Herceg, Z. (2011). Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Cancer Lett 311, 85-95.
6. Baudouin, V., Dehee, A., Pedron-Grossetete, B., Ansart-Pirenne, H., Haddad, E., Maisin, A., Loirat, C. & Sterkers, G. (2004). Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study. Transplantation 77, 1706-1713.
7. Baylin, S. B. & Herman, J. G. (2000). Epigenetics and loss of gene function in cancer. In DNA Alterations in Cancer, pp. 293-309. Edited by M. Ehrlich. Westborough: Eaton Publishing.
8. Bekkers, R. L., Van Der Avoort, I., Melchers, W. J., Bulten, J., De Wilde, P. C. & Massuger, L. F. (2005). Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia. Eur J Gynaecol Oncol 26, 376-382.
9. Bellan, C., Lazzi, S., Hummel, M., Palummo, N., De Santi, M., Amato, T., Nyagol, J., Sabattini, E., Lazure, T., Pileri, S. A., Raphael, M., Stein, H., Tosi, P. & Leoncini, L. (2005). Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106, 1031-1036.
10. Bieging, K. T., Fish, K., Bondada, S. & Longnecker, R. (2011). A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt's lymphoma. Blood 118, 6849-6859.
11. Blomen, V. A. & Boonstra, J. (2011). Stable transmission of reversible modifications: maintenance of epigenetic information through the cell cycle. Cell Mol Life Sci 68, 27-44.
12. Bonati, M. T., Asselta, R., Duga, S., Ferini-Strambi, L., Oldani, A., Zucconi, M., Malcovati, M., Dalpra, L. & Tenchini, M. L. (2000). Refined mapping of CHRNA3/A5/B4 gene cluster and its implications in ADNFLE. Neuroreport 11, 2097-2101.
13. Bossuyt, W., De Geest, N., Aerts, S., Leenaerts, I., Marynen, P. & Hassan, B. A. (2009a). The atonal proneural transcription factor links differentiation and tumor formation in Drosophila. PLoS Biol 7, e40.
14. Bossuyt, W., Kazanjian, A., De Geest, N., Van Kelst, S., De Hertogh, G., Geboes, K., Boivin, G. P., Luciani, J., Fuks, F., Chuah, M., Van Den Driessche, T., Marynen, P., Cools, J., Shroyer, N. F. & Hassan, B. A. (2009b). Atonal homolog 1 is a tumor suppressor gene. PLoS Biol 7, e39.
15. Brauninger, A., Spieker, T., Mottok, A., Baur, A. S., Kuppers, R. & Hansmann, M. L. (2003). Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur J Immunol 33, 1593-1602.
16. Brink, A. A., Dukers, D. F., Van Den Brule, A. J., Oudejans, J. J., Middeldorp, J. M., Meijer, C. J. & Jiwa, M. (1997). Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J Clin Pathol 50, 911-918.
17. Burgers, W. A., Blanchon, L., Pradhan, S., De Launoit, Y., Kouzarides, T. & Fuks, F. (2007). Viral oncoproteins target the DNA methyltransferases. Oncogene 26, 1650-1655.
18. Burkitt, D. (1958). A sarcoma involving the jaws in African children. Br J Surg 45, 218-223.
19. Burkitt, D. (1962). A children's cancer dependent upon climatic factors. Nature 194, 232-234.
20. Calvanese, V., Fernandez, A. F., Urdinguio, R. G., Suarez-Alvarez, B., Mangas, C., Perez-Garcia, V., Bueno, C., Montes, R., Ramos-Mejia, V., Martinez-Camblor, P., Ferrero, C., Assenov, Y., Bock, C., Menendez, P., Carrera, A. C., Lopez-Larrea, C. & Fraga, M. F. (2012). A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res 40, 116-131.
21. Cameron, J. E., Yin, Q., Fewell, C., Lacey, M., McBride, J., Wang, X., Lin, Z., Schaefer, B. C. & Flemington, E. K. (2008). Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 82, 1946-1958.
22. Carbone, A., Cilia, A. M., Gloghini, A., Capello, D., Fassone, L., Perin, T., Rossi, D., Canzonieri, V., De Paoli, P., Vaccher, E., Tirelli, U., Volpe, R. & Gaidano, G. (2000). Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma. Leukemia 14, 1301-1309.
23. Cazalla, D., Yario, T. & Steitz, J. A. (2010). Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563-1566.
24. Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T., Qin, J. & Zoghbi, H. Y. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229.
25. Chang, C. F., Wang, M., Fang, C. Y., Chen, P. L., Wu, S. F., Chan, M. W. & Chang, D. (2011). Analysis of DNA methylation in human BK virus. Virus Genes 43, 201-207.
26. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. (1994). Identi fication of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
27. Chau, C. M. & Lieberman, P. M. (2004). Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 78, 12308-12319.
28. Chinnasri, P., Pairojkul, C., Jearanaikoon, P., Sripa, B., Bhudhisawasdi, V., Tantimavanich, S. & Limpaiboon, T. (2009). Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Hum Pathol 40, 817-826.
29. Cotter, M. A. & Robertson, E. S. (2000). Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha. Mol Cell Biol 20, 5722-5735.
30. Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W., Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C. & Staudt, L. M. (2006). Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354, 2431-2442.
31. Davis, J. E., Sherritt, M. A., Bharadwaj, M., Morrison, L. E., Elliott, S. L., Kear, L. M., Maddicks-Law, J., Kotsimbos, T., Gill, D., Malouf, M., Falk, M. C., Khanna, R. & Moss, D. J. (2004). Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. Int Immunol 16, 983-989.
32. Day, L., Chau, C. M., Nebozhyn, M., Rennekamp, A. J., Showe, M. & Lieberman, P. M. (2007). Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81, 6389-6401.
33. De Castro Arce, J., Gockel-Krzikalla, E. & Rosl, F. (2007). Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem 282, 28520-28529.
34. De La Cruz-Hernandez, E., Perez-Plasencia, C., Perez-Cardenas, E., Gonzalez-Fierro, A., Trejo-Becerril, C., Chavez-Blanco, A., Taja-Chayeb, L., Vidal, S., Gutierrez, O., Dominguez, G. I., Trujillo, J. E. & Duenas-Gonzalez, A. (2011). Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma. Oncol Rep 25, 399-407.
35. Degner, S. C., Wong, T. P., Jankevicius, G. & Feeney, A. J. (2009). Cutting edge: developmental stage-specific recruitment of cohesin to CTCF sites throughout immunoglobulin loci during B lymphocyte development. J Immunol 182, 44-48.
36. Dinand, V. & Arya, L. S. (2006). Epidemiology of childhood Hodgkin's disease: is it different in developing countries? Indian Pediatr 43, 141-147.
37. Dong, S. M., Kim, H. S., Rha, S. H. & Sidransky, D. (2001). Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7, 1982-1986.
38. Donninger, H., Vos, M. D. & Clark, G. J. (2007). The RASSF1A tumor suppressor. J Cell Sci 120, 3163-3172.
39. Duensing, S. & Munger, K. (2003). Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 77, 12331-12335.
40. Duong, F. H., Christen, V., Filipowicz, M. & Heim, M. H. (2006). S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro. Hepatology 43, 796-806.
41. Dutton, A., Woodman, C. B., Chukwuma, M. B., Last, J. I., Wei, W., Vockerodt, M., Baumforth, K. R., Flavell, J. R., Rowe, M., Taylor, A. M., Young, L. S. & Murray, P. G. (2007). Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood 109, 2597-2603.
42. Ehrlich, M. (2000). DNA hypomethylation and cancer. In DNA Alterations in Cancer, pp. 273-291. Edited by M. Ehrlich. Westborough: Eaton Publishing.
43. Epstein, M. A., Achong, B. G. & Barr, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt's Lymphoma. Lancet 1, 702-703.
44. Feng, H., Shuda, M., Chang, Y. & Moore, P. S. (2008). Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319, 1096-1100.
45. Feng, Q., Stern, J. E., Hawes, S. E., Lu, H., Jiang, M. & Kiviat, N. B. (2010). DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 88, 287-292.
46. Fernandez, A. F., Rosales, C., Lopez-Nieva, P., Grana, O., Ballestar, E., Ropero, S., Espada, J., Melo, S. A., Lujambio, A., Fraga, M. F., Pino, I., Javierre, B., Carmona, F. J., Acquadro, F., Steenbergen, R. D., Snijders, P. J., Meijer, C. J., Pineau, P., Dejean, A., Lloveras, B., Capella, G., Quer, J., Buti, M., Esteban, J. I., Allende, H., Rodriguez-Frias, F., Castellsague, X., Minarovits, J., Ponce, J., Capello, D., Gaidano, G., Cigudosa, J. C., Gomez-Lopez, G., Pisano, D. G., Valencia, A., Piris, M. A., Bosch, F. X., Cahir-McFarland, E., Kieff, E. & Esteller, M. (2009). The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19, 438-451.
47. Flatley, J. E., McNeir, K., Balasubramani, L., Tidy, J., Stuart, E. L., Young, T. A. & Powers, H. J. (2009). Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer Epidemiol Biomarkers Prev 18, 2782-2789.
48. Formeister, E. J., Tsuchiya, M., Fujii, H., Shpyleva, S., Pogribny, I. P. & Rusyn, I. (2010). Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat Res 692, 26-33.
49. Fukayama, M., Hino, R. & Uozaki, H. (2008). Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 99, 1726-1733.
50. Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S. & Mallardo, M. (2008). Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 36, 6608-6619.
51. Gatza, M. L., Chandhasin, C., Ducu, R. I. & Marriott, S. J. (2005). Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ Mol Mutagen 45, 304-325.
52. Goossens, T., Klein, U. & Kuppers, R. (1998). Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A 95, 2463-2468.
53. Gottschalk, S., Rooney, C. M. & Heslop, H. E. (2005). Post-transplant lymphoproliferative disorders. Annu Rev Med 56, 29-44.
54. Grogg, K. L., Miller, R. F. & Dogan, A. (2007). HIV infection and lymphoma. J Clin Pathol 60, 1365-1372.
55. Gunther, T. & Grundhoff, A. (2010). The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6, e1000935.
56. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R. B., Van De Vijver, M. J., Sukumar, S. & Chang, H. Y. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076.
57. Gutierrez, M. I., Siraj, A. K., Khaled, H., Koon, N., El Rifai, W. & Bhatia, K. (2004). CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol 17, 1268-1274.
58. Hansen, J. C., Ghosh, R. P. & Woodcock, C. L. (2010). Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life 62, 732-738.
59. Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., Briem, E., Zhang, K., Irizarry, R. A. & Feinberg, A. P. (2011). Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43, 768-775.
60. He, Y. F., Li, B. Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., Sun, Y., Li, X., Dai, Q., Song, C. X., Zhang, K., He, C. & Xu, G. L. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307.
61. Hecht, J. L. & Aster, J. C. (2000). Molecular biology of Burkitt's lymphoma. J Clin Oncol 18, 3707-3721.
62. Helmbold, P., Lahtz, C., Enk, A., Herrmann-Trost, P., Marsch, W. C., Kutzner, H. & Dammann, R. H. (2009). Frequent occurrence of RASSF1A promoter hypermethylation and Merkel cell polyomavirus in Merkel cell carcinoma. Mol Carcinog 48, 903-909.
63. Helt, A. M. & Galloway, D. A. (2003). Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24, 159-169.
64. Henken, F. E., Wilting, S. M., Overmeer, R. M., Van Rietschoten, J. G., Nygren, A. O., Errami, A., Schouten, J. P., Meijer, C. J., Snijders, P. J. & Steenbergen, R. D. (2007). Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 97, 1457-1464.
65. Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Muller-Lantzsch, N. & Stein, H. (1991). Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A 88, 4766-4770.
66. Higgs, M. R., Lerat, H. & Pawlotsky, J. M. (2010). Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 70, 4901-4911.
67. Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K. & Fukayama, M. (2009). Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69, 2766-2774.
68. Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J. S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H. & Melbye, M. (2003). Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349, 1324-1332.
69. Hjalgrim, H. & Engels, E. A. (2008). Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med 264, 537-548.
70. Holland, D., Hoppe-Seyler, K., Schuller, B., Lohrey, C., Maroldt, J., Durst, M. & Hoppe-Seyler, F. (2008). Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 68, 9964-9972.
71. Howie, H. L., Katzenellenbogen, R. A. & Galloway, D. A. (2009). Papillomavirus E6 proteins. Virology 384, 324-334.
72. Hsu, C. H., Peng, K. L., Jhang, H. C., Lin, C. H., Wu, S. Y., Chiang, C. M., Lee, S. C., Yu, W. C. & Juan, L. J. (2011). The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene. doi: 10.1038/onc.2011.415.
73. Hu, J., Dong, A., Fernandez-Ruiz, V., Shan, J., Kawa, M., Martinez-Anso, E., Prieto, J. & Qian, C. (2009). Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 69, 6951-6959.
74. Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F., Bernd, H. W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., Hansmann, M. L., Haralambieva, E., Harder, L., Hasenclever, D., Kuhn, M., Lenze, D., Lichter, P., Martin-Subero, J. I., Moller, P., Muller-Hermelink, H. K., Ott, G., Parwaresch, R. M., Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Sturzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H. H., Spang, R., Loeffler, M., Trumper, L., Stein, H. & Siebert, R. (2006). A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354, 2419-2430.
75. Hung, T. & Chang, H. Y. (2010). Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol 7, 582-585.
76. Hutzinger, R., Feederle, R., Mrazek, J., Schiefermeier, N., Balwierz, P. J., Zavolan, M., Polacek, N., Delecluse, H. J. & Huttenhofer, A. (2009). Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog 5, e1000547.
77. Hyland, P. L., McDade, S. S., McCloskey, R., Dickson, G. J., Arthur, K., McCance, D. J. & Patel, D. (2011). Evidence for Alteration of EZH2, BMI1, and KDM6A and Epigenetic Reprogramming in Human Papillomavirus Type 16 E6/E7-Expressing Keratinocytes. J Virol 85, 10999-11006.
78. Iaquinta, P. J. & Lees, J. A. (2007). Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19, 649-657.
79. Issa, J. P. (2011). Epigenetic variation and cellular Darwinism. Nat Genet 43, 724-726.
80. Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C. & Zhang, Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303.
81. Janas, J. A. & Van Aelst, L. (2011). Oncogenic tyrosine kinases target Dok-1 for ubiquitinmediated proteasomal degradation to promote cell transformation. Mol Cell Biol 31, 2552-2565.
82. Jarrett, R. F. (2003). Risk factors for Hodgkin's lymphoma by EBV status and signi ficance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma 44 Suppl 3, S27-S32.
83. Kamdar, K. Y., Rooney, C. M. & Heslop, H. E. (2011). Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant 16, 274-280.
84. Kang, G. H., Lee, S., Cho, N. Y., Gandamihardja, T., Long, T. I., Weisenberger, D. J., Campan, M. & Laird, P. W. (2008). DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest 88, 161-170.
85. Kang, H., Wiedmer, A., Yuan, Y., Robertson, E. & Lieberman, P. M. (2011). Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog 7, e1002140.
86. Katoh, H., Shibata, T., Kokubu, A., Ojima, H., Fukayama, M., Kanai, Y. & Hirohashi, S. (2006). Epigenetic instability and chromosomal instability in hepatocellular carcinoma. Am J Pathol 168, 1375-1384.
87. Kaur, P., Paliwal, A., Durantel, D., Hainaut, P., Scoazec, J. Y., Zoulim, F., Chemin, I. & Herceg, Z. (2010). DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J Infect Dis 202, 700-704.
88. Kelly, G., Bell, A. & Rickinson, A. (2002). Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8, 1098-1104.
89. Kimura, H., Nakamura, T., Ogawa, T., Tanaka, S. & Shiota, K. (2003). Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. Nucleic Acids Res 31, 3101-3113.
90. Kinoshita, T., Nomoto, S., Kodera, Y., Koike, M., Fujiwara, M. & Nakao, A. (2011). Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancer. Hepatogastroenterology 58, 1051-1056.
91. Kitkumthorn, N., Yanatatsanajit, P., Kiatpongsan, S., Phokaew, C., Triratanachat, S., Trivijitsilp, P., Termrungruanglert, W., Tresukosol, D., Niruthisard, S. & Mutirangura, A. (2006). Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 6:55.
92. Knight, J. S., Lan, K., Subramanian, C. & Robertson, E. S. (2003). Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77, 4261-4272.
93. Ko, E., Kim, S. J., Joh, J. W., Park, C. K., Park, J. & Kim, D. H. (2008). CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma. Cancer Lett 271, 240-250.
94. Kohno, T., Kunitoh, H., Mimaki, S., Shiraishi, K., Kuchiba, A., Yamamoto, S. & Yokota, J. (2011). Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol 6, 813-817.
95. Kremer, B. E., Reshef, R., Misleh, J. G., Christie, J. D., Ahya, V. N., Blumenthal, N. P., Kotloff, R. M., Hadjiliadis, D., Stadtmauer, E. A., Schuster, S. J. & Tsai, D. E. (2011). Posttransplant lymphoproliferative disorder after lung transplantation: A review of 35 cases. J Heart Lung Transplant 31, 296-304.
96. Krishna, S. M., Kattoor, J. & Balaram, P. (2005). Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas. Cancer Biomark 1, 271-277.
97. Krithivas, A., Young, D. B., Liao, G., Greene, D. & Hayward, S. D. (2000). Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74, 9637-9645.
98. Kuppers, R. (2009). The biology of Hodgkin's lymphoma. Nat Rev Cancer 9, 15-27.
99. Kuppers, R., Klein, U., Schwering, I., Distler, V., Brauninger, A., Cattoretti, G., Tu, Y., Stolovitzky, G. A., Califano, A., Hansmann, M. L. & Dalla-Favera, R. (2003). Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 111, 529-537.
100. Kuppers, R., Schwering, I., Brauninger, A., Rajewsky, K. & Hansmann, M. L. (2002). Biology of Hodgkin's lymphoma. Ann Oncol 13 Suppl 1, 11-18.
101. Kurth, J., Hansmann, M. L., Rajewsky, K. & Kuppers, R. (2003). Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A 100, 4730-4735.
102. Kwong, J., Lo, K. W., Chow, L. S., Chan, F. L., To, K. F. & Huang, D. P. (2005a). Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer 113, 386-392.
103. Kwong, J., Lo, K. W., Chow, L. S., To, K. F., Choy, K. W., Chan, F. L., Mok, S. C. & Huang, D. P. (2005b). Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia 7, 67-74.
104. Kwong, J., Lo, K. W., To, K. F., Teo, P. M., Johnson, P. J. & Huang, D. P. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8, 131-137.
105. Lai, H. C., Lin, Y. W., Huang, R. L., Chung, M. T., Wang, H. C., Liao, Y. P., Su, P. H., Liu, Y. L. & Yu, M. H. (2010). Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 116, 4266-4274.
106. Lai, H. C., Lin, Y. W., Huang, T. H., Yan, P., Huang, R. L., Wang, H. C., Liu, J., Chan, M. W., Chu, T. Y., Sun, C. A., Chang, C. C. & Yu, M. H. (2008). Identi fication of novel DNA methylation markers in cervical cancer. Int J Cancer 123, 161-167.
107. Lambert, M. P., Paliwal, A., Vaissiere, T., Chemin, I., Zoulim, F., Tommasino, M., Hainaut, P., Sylla, B., Scoazec, J. Y., Tost, J. & Herceg, Z. (2011). Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54, 705-715.
108. Laurent-Puig, P. & Zucman-Rossi, J. (2006). Genetics of hepatocellular tumors. Oncogene 25, 3778-3786.
109. Lee, T. S., Kim, J. W., Kang, G. H., Park, N. H., Song, Y. S., Kang, S. B. & Lee, H. P. (2006). DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix. Ann N Y Acad Sci 1091, 218-224.
110. Lenze, D., Leoncini, L., Hummel, M., Volinia, S., Liu, C. G., Amato, T., De Falco, G., Githanga, J., Horn, H., Nyagol, J., Ott, G., Palatini, J., Pfreundschuh, M., Rogena, E., Rosenwald, A., Siebert, R., Croce, C. M. & Stein, H. (2011). The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia 25, 1869-1876.
111. Leonard, S., Wei, W., Anderton, J., Vockerodt, M., Rowe, M., Murray, P. G. & Woodman, C. B. (2011). Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma. J Virol 85, 9568-9577.
112. Levens, D. L. (2003). Reconstructing MYC. Genes Dev 17, 1071-1077.
113. Li, G., Wu, Z., Peng, Y., Liu, X., Lu, J., Wang, L., Pan, Q., He, M. L. & Li, X. P. (2010). MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 299, 29-36.
114. Li, X., Hui, A. M., Sun, L., Hasegawa, K., Torzilli, G., Minagawa, M., Takayama, T. & Makuuchi, M. (2004). p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res 10, 7484-7489.
115. Lim, C., Lee, D., Seo, T., Choi, C. & Choe, J. (2003). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem 278, 7397-7405.
116. Lin, I. G., Tomzynski, T. J., Ou, Q. & Hsieh, C. L. (2000). Modulation of DNA binding protein affinity directly affects target site demethylation. Mol Cell Biol 20, 2343-2349.
117. Ling, P. D., Tan, J. & Peng, R. (2009). Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function. J Virol 83, 7109-7116.
118. Liu, L., Tommasi, S., Lee, D. H., Dammann, R. & Pfeifer, G. P. (2003). Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22, 8125-8136.
119. Lo, A. K., To, K. F., Lo, K. W., Lung, R. W., Hui, J. W., Liao, G. & Hayward, S. D. (2007). Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A 104, 16164-16169.
120. Lupberger, J. & Hildt, E. (2007). Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13, 74-81.
121. Machida, K., Cheng, K. T., Sung, V. M., Shimodaira, S., Lindsay, K. L., Levine, A. M., Lai, M. Y. & Lai, M. M. (2004). Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101, 4262-4267.
122. Magrath, I., Jain, V. & Bhatia, K. (1992). Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 3, 285-295.
123. Martin-Subero, J. I., Kreuz, M., Bibikova, M., Bentink, S., Ammerpohl, O., Wickham-Garcia, E., Rosolowski, M., Richter, J., Lopez-Serra, L., Ballestar, E., Berger, H., Agirre, X., Bernd, H. W., Calvanese, V., Cogliatti, S. B., Drexler, H. G., Fan, J. B., Fraga, M. F., Hansmann, M. L., Hummel, M., Klapper, W., Korn, B., Kuppers, R., Macleod, R. A., Moller, P., Ott, G., Pott, C., Prosper, F., Rosenwald, A., Schwaenen, C., Schubeler, D., Seifert, M., Sturzenhofecker, B., Weber, M., Wessendorf, S., Loeffler, M., Trumper, L., Stein, H., Spang, R., Esteller, M., Barker, D., Hasenclever, D. & Siebert, R. (2009). New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113, 2488-2497.
124. Massari, M. E., Rivera, R. R., Voland, J. R., Quong, M. W., Breit, T. M., Van Dongen, J. J., De Smit, O. & Murre, C. (1998). Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol 18, 3130-3139.
125. Matsumura, S., Persson, L. M., Wong, L. & Wilson, A. C. (2010). The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. J Virol 84, 2318-2330.
126. Mattsson, K., Kiss, C., Platt, G. M., Simpson, G. R., Kashuba, E., Klein, G., Schulz, T. F. & Szekely, L. (2002). Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J Gen Virol 83, 179-188.
127. McCabe, M. T., Low, J. A., Daignault, S., Imperiale, M. J., Wojno, K. J. & Day, M. L. (2006). Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res 66, 385-392.
128. McLaughlin-Drubin, M. E., Crum, C. P. & Munger, K. (2011). Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A 108, 2130-2135.
129. McLaughlin-Drubin, M. E. & Munger, K. (2009). The human papillomavirus E7 oncoprotein. Virology 384, 335-344.
130. Meng, Y., Wang, Q. G., Wang, J. X., Zhu, S. T., Jiao, Y., Li, P. & Zhang, S. T. (2011). Epigenetic Inactivation of the SFRP1 Gene in Esophageal Squamous Cell Carcinoma. Dig Dis Sci 56, 3195-3203.
131. Minarovits, J. (2006). Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 310, 61-80.
132. Minarovits, J., Hu, L. F., Minarovits-Kormuta, S., Klein, G. & Ernberg, I. (1994). Sequencespecific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancerpromoter regions. Virology 200, 661-667.
133. Motsch, N., Pfuhl, T., Mrazek, J., Barth, S. & Grasser, F. A. (2007). Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 4, 131-137.
134. Mrazek, J., Kreutmayer, S. B., Grasser, F. A., Polacek, N. & Huttenhofer, A. (2007). Subtractive hybridization identi fies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 35, e73.
135. Muti, G., Klersy, C., Baldanti, F., Granata, S., Oreste, P., Pezzetti, L., Gatti, M., Gargantini, L., Caramella, M., Mancini, V., Gerna, G. & Morra, E. (2003). Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Br J Haematol 122, 927-933.
136. Naka, K., Abe, K., Takemoto, K., Dansako, H., Ikeda, M., Shimotohno, K. & Kato, N. (2006). Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells. J Hepatol 44, 869-878.
137. Nakase, K., Cheng, J., Zhu, Q. & Marasco, W. A. (2009). Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells. J Leukoc Biol 85, 165-174.
138. Nan, X., Cross, S. & Bird, A. (1998a). Gene silencing by methyl-CpG-binding proteins. Novartis Found Symp 214, 6-16.
139. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. & Bird, A. (1998b). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389.
140. Narimatsu, T., Tamori, A., Koh, N., Kubo, S., Hirohashi, K., Yano, Y., Arakawa, T., Otani, S. & Nishiguchi, S. (2004). p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology 47, 26-31.
141. Niemhom, S., Kitazawa, S., Kitazawa, R., Maeda, S. & Leopairat, J. (2008). Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detect Prev 32, 127-134.
142. Niller, H. H., Salamon, D., Banati, F., Schwarzmann, F., Wolf, H. & Minarovits, J. (2004a). The LCR of EBV makes Burkitt's lymphoma endemic. Trends Microbiol 12, 495-499.
143. Niller, H. H., Salamon, D., Ilg, K., Koroknai, A., Banati, F., Bauml, G., Rucker, O., Schwarzmann, F., Wolf, H. & Minarovits, J. (2003). The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9, HY1-HY9.
144. Niller, H. H., Salamon, D., Ilg, K., Koroknai, A., Banati, F., Schwarzmann, F., Wolf, H. & Minarovits, J. (2004b). EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62, 387-391.
145. Niller, H. H., Salamon, D., Rahmann, S., Ilg, K., Koroknai, A., Banati, F., Schwarzmann, F., Wolf, H. & Minarovits, J. (2004c). A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review. Acta Microbiol Immunol Hung 51, 469-484.
146. Niller, H. H., Wolf, H. & Minarovits, J. (2007). Epstein-Barr Virus. In Latency Strategies of Herpesviruses, pp. 154-191. Edited by J. Minarovits, E. Gonczol & T. Valyi-Nagy. New York: Springer.
147. Niller, H. H., Wolf, H. & Minarovits, J. (2008). Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41, 298-328.
148. Niller, H. H., Wolf, H. & Minarovits, J. (2009). Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 19, 158-164.
149. Niller, H. H., Wolf, H. & Minarovits, J. (2011). Viral hit and run-oncogenesis: Genetic and epigenetic scenarios. Cancer Lett 305, 200-217.
150. Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M. & Young, L. S. (1991). Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337, 320-322.
151. Pantry, S. N. & Medveczky, P. G. (2009). Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin Cancer Biol 19, 153-157.
152. Park, I. Y., Sohn, B. H., Yu, E., Suh, D. J., Chung, Y. H., Lee, J. H., Surzycki, S. J. & Lee, Y. I. (2007). Aberrant epigenetic modi fications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132, 1476-1494.
153. Pelengaris, S., Khan, M. & Evan, G. I. (2002). Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334.
154. Piccaluga, P. P., De Falco, G., Kustagi, M., Gazzola, A., Agostinelli, C., Tripodo, C., Leucci, E., Onnis, A., Astolfi, A., Sapienza, M. R., Bellan, C., Lazzi, S., Tumwine, L., Mawanda, M., Ogwang, M., Calbi, V., Formica, S., Califano, A., Pileri, S. A. & Leoncini, L. (2011). Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 117, 3596-3608.
155. Platt, G., Carbone, A. & Mittnacht, S. (2002). p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene 21, 1823-1831.
156. Portal, D., Rosendorff, A. & Kieff, E. (2006). Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc Natl Acad Sci U S A 103, 19278-19283.
157. Raab-Traub, N. & Flynn, K. (1986). The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47, 883-889.
158. Rahadiani, N., Takakuwa, T., Tresnasari, K., Morii, E. & Aozasa, K. (2008). Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem Biophys Res Commun 377, 579-583.
159. Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O. & Ganem, D. (2001). Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75, 458-468.
160. Ringrose, L. & Paro, R. (2007). Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development 134, 223-232.
161. Roh, T. Y., Cuddapah, S. & Zhao, K. (2005). Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 19, 542-552.
162. Rossetto, C. C. & Pari, G. S. (2011). Kaposi's Sarcoma-Associated Herpesvirus Noncoding Polyadenylated Nuclear RNA Interacts with Virus- and Host Cell-Encoded Proteins and Suppresses Expression of Genes Involved in Immune Modulation. J Virol 85, 13290-13297.
163. Rossi, D., Gaidano, G., Gloghini, A., Deambrogi, C., Franceschetti, S., Berra, E., Cerri, M., Vendramin, C., Conconi, A., Viglio, A., Muti, G., Oreste, P., Morra, E., Paulli, M., Capello, D. & Carbone, A. (2003). Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiencyrelated lymphomas. Br J Haematol 123, 475-478.
164. Rossi, G. & Bonetti, F. (2004). EBV and Burkitt's lymphoma. N Engl J Med 350, 2621.
165. Roughan, J. E., Torgbor, C. & Thorley-Lawson, D. A. (2010). Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol 84, 1158-1168.
166. Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H. & Hirohashi, S. (2002). Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci U S A 99, 10060-10065.
167. Sakakibara, S., Ueda, K., Nishimura, K., Do, E., Ohsaki, E., Okuno, T. & Yamanishi, K. (2004). Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol 78, 7299-7310.
168. Sakuma, K., Chong, J. M., Sudo, M., Ushiku, T., Inoue, Y., Shibahara, J., Uozaki, H., Nagai, H. & Fukayama, M. (2004). High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 112, 273-278.
169. ∗ and C-promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. J Gen Virol.
170. Saulnier, A., Vaissiere, T., Yue, J., Siouda, M., Malfroy, M., Accardi, R., Creveaux, M., Sebastian, S., Shahzad, N., Gheit, T., Hussain, I., Torrente, M., Maffini, F. A., Calabrese, L., Chiesa, F., Cuenin, C., Shukla, R., Fathallah, I., Matos, E., Daudt, A., Koifman, S., Wunsch-Filho, V., Menezes, A. M., Curado, M. P., Zaridze, D., Boffetta, P., Brennan, P., Tommasino, M., Herceg, Z. & Sylla, B. S. (2011). Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers. Int J Cancer 130, 2484-2894.
171. Shamay, M., Krithivas, A., Zhang, J. & Hayward, S. D. (2006). Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci U S A 103, 14554-14559.
172. Shi, N., Ye, S., Bartlam, M., Yang, M., Wu, J., Liu, Y., Sun, F., Han, X., Peng, X., Qiang, B., Yuan, J. & Rao, Z. (2004). Structural basis for the specific recognition of RET by the Dok1 phosphotyrosine binding domain. J Biol Chem 279, 4962-4969.
173. Shikauchi, Y., Saiura, A., Kubo, T., Niwa, Y., Yamamoto, J., Murase, Y. & Yoshikawa, H. (2009). SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma. Mol Cell Biol 29, 1944-1958.
174. Shim, Y. H., Yoon, G. S., Choi, H. J., Chung, Y. H. & Yu, E. (2003). p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett 190, 213-219.
175. Sriraksa, R., Zeller, C., El Bahrawy, M. A., Dai, W., Daduang, J., Jearanaikoon, P., Chau-In, S., Brown, R. & Limpaiboon, T. (2011). CpG-island methylation study of liver fluke-related cholangiocarcinoma. Br J Cancer 104, 1313-1318.
176. Sriuranpong, V., Mutirangura, A., Gillespie, J. W., Patel, V., Amornphimoltham, P., Molinolo, A. A., Kerekhanjanarong, V., Supanakorn, S., Supiyaphun, P., Rangdaeng, S., Voravud, N. & Gutkind, J. S. (2004). Global gene expression pro file of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 10, 4944-4958.
177. Staudt, L. M. & Dave, S. (2005). The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 87, 163-208.
178. Stedman, W., Deng, Z., Lu, F. & Lieberman, P. M. (2004). ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 78, 12566-12575.
179. Stevens, S. J., Verschuuren, E. A., Pronk, I., Van Der Bij W., Harmsen, M. C., The, T. H., Meijer, C. J., Van Den Brule, A. J. & Middeldorp, J. M. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97, 1165-1171.
180. Stuber, G., Mattsson, K., Flaberg, E., Kati, E., Markasz, L., Sheldon, J. A., Klein, G., Schulz, T. F. & Szekely, L. (2007). HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus. Mol Cancer 6:28.
181. Su, P. F., Lee, T. C., Lin, P. J., Lee, P. H., Jeng, Y. M., Chen, C. H., Liang, J. D., Chiou, L. L., Huang, G. T. & Lee, H. S. (2007). Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int J Cancer 121, 1257-1264.
182. Swaminathan, S. (2008). Noncoding RNAs produced by oncogenic human herpesviruses. J Cell Physiol 216, 321-326.
183. Szalmas, A. & Konya, J. (2009). Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol 19, 144-152.
184. Takacs, M., Banati, F., Koroknai, A., Segesdi, J., Salamon, D., Wolf, H., Niller, H. H. & Minarovits, J. (2010). Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim Biophys Acta 1799, 228-235.
185. Takacs, M., Segesdi, J., Banati, F., Koroknai, A., Wolf, H., Niller, H. H. & Minarovits, J. (2009). The importance of epigenetic alterations in the development of Epstein-Barr virusrelated lymphomas. Mediterr J Hematol Infect Dis 1, e2009012.
186. Takai, N., Kira, N., Ishii, T., Nishida, M., Nasu, K. & Narahara, H. (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev 12, 575-580.
187. Tanner, J. E. & Alfieri, C. (2001). The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis 3, 60-69.
188. Tempera, I., Klichinsky, M. & Lieberman, P. M. (2011). EBV latency types adopt alternative chromatin conformations. PLoS Pathog 7, e1002180.
189. Tempera, I. & Lieberman, P. M. (2010). Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 1799, 236-245.
190. Ter Schegget, J., Voves, J., Van Strien, A. & Van Der Noordaa J. (1980). Free viral DNA in BK virus-induced hamster tumor cells. J Virol 35, 331-339.
191. Thorley-Lawson, D. A. (2004). EBV and Burkitt's lymphoma. N Engl J Med 350, 2621.
192. Timms, J. M., Bell, A., Flavell, J. R., Murray, P. G., Rickinson, A. B., Traverse-Glehen, A., Berger, F. & Delecluse, H. J. (2003). Target cells of Epstein-Barr-virus (EBV)-positive posttransplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet 361, 217-223.
193. Tischoff, I. & Tannapfel, A. (2008). DNA methylation in hepatocellular carcinoma. World J Gastroenterol 14, 1741-1748.
194. Tobollik, S., Meyer, L., Buettner, M., Klemmer, S., Kempkes, B., Kremmer, E., Niedobitek, G. & Jungnickel, B. (2006). Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth. Blood 108, 3859-3864.
195. Toth, Z., Maglinte, D. T., Lee, S. H., Lee, H. R., Wong, L. Y., Brulois, K. F., Lee, S., Buckley, J. D., Laird, P. W., Marquez, V. E. & Jung, J. U. (2010). Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6, e1001013.
196. Tsai, C. L., Li, H. P., Lu, Y. J., Hsueh, C., Liang, Y., Chen, C. L., Tsao, S. W., Tse, K. P., Yu, J. S. & Chang, Y. S. (2006). Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun. NH (2)-terminal kinase signaling. Cancer Res 66, 11668-11676.
197. Tsai, C. N., Tsai, C. L., Tse, K. P., Chang, H. Y. & Chang, Y. S. (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 99, 10084-10089.
198. Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N. & Kikutani, H. (1999). Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286, 300-303.
199. Um, T. H., Kim, H., Oh, B. K., Kim, M. S., Kim, K. S., Jung, G. & Park, Y. N. (2011). Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 54, 939-947.
200. Umehara, T., Nakamura, Y., Wakamori, M., Ozato, K., Yokoyama, S. & Padmanabhan, B. (2010). Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. FEBS Lett 584, 3901-3908.
201. Ushiku, T., Chong, J. M., Uozaki, H., Hino, R., Chang, M. S., Sudo, M., Rani, B. R., Sakuma, K., Nagai, H. & Fukayama, M. (2007). p73 gene promoter methylation in Epstein-Barr virusassociated gastric carcinoma. Int J Cancer 120, 60-66.
202. Ushmorov, A., Leithauser, F., Ritz, O., Barth, T. F., Moller, P. & Wirth, T. (2008). ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. Leukemia 22, 1942-1944.
203. Van Den Bosch, C. A. (2004). Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol 5, 738-746.
204. Van Keymeulen, A., Mascre, G., Youseff, K. K., Harel, I., Michaux, C., De Geest, N., Szpalski, C., Achouri, Y., Bloch, W., Hassan, B. A. & Blanpain, C. (2009). Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 187, 91-100.
205. Viejo-Borbolla, A., Ottinger, M., Bruning, E., Burger, A., Konig, R., Kati, E., Sheldon, J. A. & Schulz, T. F. (2005). Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 79, 13618-13629.
206. Wang, L., Grossman, S. R. & Kieff, E. (2000). Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci U S A 97, 430-435.
207. Wentzensen, N., Sherman, M. E., Schiffman, M. & Wang, S. S. (2009). Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112, 293-299.
208. Wisman, G. B., Nijhuis, E. R., Hoque, M. O., Reesink-Peters, N., Koning, A. J., Volders, H. H., Buikema, H. J., Boezen, H. M., Hollema, H., Schuuring, E., Sidransky, D. & Van Der Zee, A. G. (2006). Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119, 1908-1914.
209. Yanatatsaneejit, P., Mutirangura, A. & Kitkumthorn, N. (2011). Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer. Int J Gynecol Cancer 21, 902-906.
210. Yang, B., Guo, M., Herman, J. G. & Clark, D. P. (2003). Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163, 1101-1107.
211. Yasui, D. H., Peddada, S., Bieda, M. C., Vallero, R. O., Hogart, A., Nagarajan, R. P., Thatcher, K. N., Farnham, P. J. & LaSalle, J. M. (2007). Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A 104, 19416-19421.
212. Zhang, B., Laribee, R. N., Klemsz, M. J. & Roman, A. (2004). Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes. Virology 329, 189-198.
213. Zhang, Y. J., Chen, Y., Ahsan, H., Lunn, R. M., Chen, S. Y., Lee, P. H., Chen, C. J. & Santella, R. M. (2005). Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 221, 135-143.
214. Zheng, Z., Pan, J., Chu, B., Wong, Y. C., Cheung, A. L. & Tsao, S. W. (1999). Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 30, 458-466.
215. Zhong, S., Yeo, W., Tang, M. W., Wong, N., Lai, P. B. & Johnson, P. J. (2003). Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 9, 3376-3382.
216. Zhou, J., Chau, C. M., Deng, Z., Shiekhattar, R., Spindler, M. P., Schepers, A. & Lieberman, P. M. (2005). Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J 24, 1406-1417.
217. Zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342-350.